Which cancer drug pipeline bets will pay off?

Wednesday, June 3, 2026 | 11:00 AM - 1:00 PM ET

ASCO is where oncology pipelines face their moment of truth. Readouts can validate years of R&D investment or send billion-dollar programs back to square one. Multiple critical data drops could either pave the way for novel mechanisms or expose fundamental flaws in approach. 

We're assembling a panel of oncology insiders to break down the readouts to watch and where the field is actually headed over the next year. Join us.

SPONSORED BY

Sponsorship opportunities are available.
Contact Meg at mestacio@endpointsnews.com to learn how you can support Endpoints' ASCO 2026.